U.S. Telecom Services and Carriers Stock News

NXP Semiconductors recently reported its fourth quarter and full-year 2025 results, showing quarterly sales rising to US$3,335 million while full-year sales edged down to US$12.27 billion and net income declined to US$2.02 billion, and also issued first quarter 2026 guidance calling for revenue between US$3,050 million and US$3,250 million with diluted EPS of US$4.01 to US$4.41. Alongside the guidance and earnings release, the company announced that long-serving Executive Vice President and...

In recent weeks, Warren E III Hoffner, Applied Industrial Technologies’ VP and General Manager of Fluid Power, sold 4,000 company shares, while management reiterated confidence in order momentum, engineered solutions, and cash generation despite accounting-driven margin pressures. Alongside this insider sale, Applied emphasized support for its long-term business direction through ongoing bolt-on acquisitions like Thompson Industrial Supply and an 11% dividend increase. With management’s...

Granite Construction (GVA) is back in focus after reporting better-than-expected Q4 and full-year 2025 results, paired with a new Interstate 80 East Widening preconstruction contract that adds to its public infrastructure workload. See our latest analysis for Granite Construction. The latest earnings beat, new Interstate 80 preconstruction award and a recently affirmed quarterly dividend have come alongside a 30 day share price return of 7.89% and a 90 day share price return of 29.05%, while...

Earnings, special dividend and higher regular payout put CNA Financial in focus CNA Financial (CNA) is back on investor radar after reporting fourth quarter and full year 2025 earnings, while also announcing a US$2.00 per share special dividend and a higher regular quarterly dividend. See our latest analysis for CNA Financial. At a share price of US$48.69, CNA’s recent 30 day share price return of 4.98% and 90 day share price return of 6.33% sit alongside a 1 year total shareholder return of...

Gartner (IT) is under pressure after weak fourth quarter contract value figures, cautious 2026 guidance, a sharp share price drop, and new securities law investigations into its financial disclosures and use of non GAAP metrics. See our latest analysis for Gartner. Those weak contract value figures, cautious 2026 outlook, and the new securities law investigations line up with a sharp reset in sentiment. A 30 day share price return of 31.25% decline and a 1 year total shareholder return of...

In early February 2026, Horace Mann Educators Corporation reported its full-year 2025 results, with revenue of US$1,701.4 million and net income of US$162.1 million, both higher than the prior year. The sharp increase in net income versus 2024 suggests that Horace Mann’s underlying profitability improved meaningfully over the year, beyond simple top-line expansion. We’ll now examine how this stronger full-year revenue and earnings performance may influence Horace Mann’s existing investment...

ARK Invest has purchased NYSE:BLSH shares for ten consecutive trading days, signaling ongoing institutional interest. Bullish recently secured approval for a New York BitLicense, expanding its regulatory footprint in a key U.S. market. The BitLicense allows Bullish to broaden custody services and access a wider pool of professional clients in New York. For Bullish, ticker NYSE:BLSH, the combination of steady ARK Invest buying and a New York BitLicense arrives at a time when the broader...

With no single headline event driving it today, 10x Genomics (TXG) is experiencing a combination of mixed recent share returns and ongoing interest in its genomics tools business, prompting closer attention from investors. See our latest analysis for 10x Genomics. The recent 3.5% 1 day share price gain to US$18.12 sits against a 30 day share price return of 12% and a 1 year total shareholder return of 47%. However, the 3 and 5 year total shareholder returns remain sharply negative, suggesting...

Snap-on reported fourth-quarter 2025 results with sales of US$1,231.9 million and diluted EPS of US$4.94, alongside a US$2.44 quarterly dividend declared for payment on March 10, 2026 to shareholders of record on February 24, 2026. While revenue growth was modest and earnings eased slightly for the full year, Snap-on’s uninterrupted quarterly dividend record since 1939 underscores how management is prioritizing consistent shareholder returns amid a turbulent demand backdrop. Now we’ll assess...

PHINIA Inc. (NYSE:PHIN) reported year over year growth across key business segments in 2025. The company recorded three consecutive quarters of growth in both Fuel Systems and Aftermarket segments. Management reduced debt, improved leverage, and expressed optimism for 2026. Leadership is targeting further market share gains in areas such as Gasoline Direct Injection and alternative fuels. PHINIA, trading as NYSE:PHIN, focuses on Fuel Systems and Aftermarket products that support internal...

Why Merck stock is back in focus Merck (MRK) is back on investors radars after the FDA approved KEYTRUDA and its subcutaneous QLEX formulation for platinum-resistant ovarian cancer, alongside fresh oncology data heading to the 2026 ASCO GU symposium. This new indication makes KEYTRUDA the first PD-1 inhibitor cleared for this difficult ovarian cancer population, supported by Phase 3 results. The upcoming genitourinary presentations highlight how central oncology remains to Merck's long-term...

If you are wondering whether Alkermes at around US$33.16 is offering good value right now, this article will walk through what the numbers actually suggest. The share price performance shows a mixed picture, with a 5% decline over the last 7 days, a 4.8% gain over the last 30 days, a 17.3% gain year to date, and a 7.6% decline over the last year alongside gains of 20.1% over 3 years and 72.1% over 5 years. Recent coverage has focused on Alkermes as a long established player in the...

Match Group reported past fourth-quarter 2025 sales of US$878.01 million and net income of US$209.65 million, alongside full-year 2025 sales of US$3.49 billion and a higher annual profit, while also updating its 2026 revenue outlook to be roughly flat year-on-year. Alongside the earnings release, Match Group raised its quarterly dividend, completed a sizeable share repurchase program, and highlighted cost savings that are being redirected into AI-driven product innovation and...

What ABM Industries (ABM) investors may be watching now ABM Industries (ABM) recently closed at $44.51, with shares showing a 2.46% move over the past day, a small decline over the past month, and a gain across the past 3 months. See our latest analysis for ABM Industries. That 2.46% 1 day share price gain comes after a 6.41% 7 day share price pullback. The 90 day share price return of 10.42% suggests momentum has been rebuilding even as the 1 year total shareholder return of 13.92% remains...

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...

Costco Wholesale (COST) is back in focus after reporting January net sales of US$21.33b, up 9.3% year over year, with digital and e-commerce channels taking a larger share of revenue. See our latest analysis for Costco Wholesale. The latest US$21.33b January sales update and growing digital mix come on top of strong price momentum, with Costco’s 30 day share price return of 5.69% and year to date share price return of 19.19%, while its 3 year total shareholder return of 109.03% contrasts with...

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...

IBM has agreed to acquire Confluent in a definitive deal, bringing the data streaming specialist into its broader enterprise software portfolio. The agreement follows strong quarterly revenue and earnings results from Confluent, which trades under ticker NasdaqGS:CFLT. The transaction marks a major ownership shift for Confluent shareholders at a current share price of $30.56. For investors watching NasdaqGS:CFLT, this deal comes after a mixed share price record, with the stock up 20.5% over...

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...

Wondering if Klarna Group at US$18.11 is a bargain or a value trap? This article walks you through what the current price might really be telling you. The stock has recently seen sharp moves, with a 7 day return of an 11.7% decline and a 30 day return of a 37.6% decline, and it sits 36.6% below its year to date level. Recent headlines around Klarna Group have kept investor attention on the business model and competitive position, which helps frame these price swings. This article uses that...

Crane NXT recently reported past quarterly results showing around 20% year-on-year sales growth in Q4 2025 and 11% for 2025 overall, driven by strong demand in its currency and authentication technology businesses, new wins across 20 currency denominations, and renewed multiyear contracts with major sports leagues. The company is also expanding capacity in its international currency operations and moving to acquire Antares Vision by mid-2026, highlighting how its micro-optics and...

On 12 February 2026, BioLife Solutions, Inc. announced a multi-year agreement to distribute Qkine Limited’s cytokine and growth factor products globally for cell and gene therapy manufacturing, with plans to integrate select products into BioLife’s CellSeal® Connect vial system. This deal broadens BioLife’s reach into the US$500 million cytokines market, which third-party research suggests could reach about US$1.00 billion by 2030, directly linking its biopreservation tools with critical CGT...